Accine Packaging Market to Exceed US $ 1.15 Billion in 2021 and Show a CAGR of 13.1% between 2020 and 2030

0


Vaccine Packaging Market

Vials represent 4 / 5th of vaccine packaging in 2021: new study

JUMEIRAH LAKES TOWERS, DUBAI, UNITED ARAB EMIRATES, December 13, 2021 /EINPresswire.com/ – Future Market Insights (IMF) in a recent study provided for the vaccine packaging market to exceed US $ 1.15 billion in 2021. Advances in immunization, mainly in developed countries, have been driven by widespread awareness of its benefits, access to vaccines, and ongoing public and private efforts to encourage their use as an important part of care. health and prevention.

Developing regions have also started to take initiatives in public immunization programs regularly organized by government agencies. This is mainly because consumers and regulators are seeing a sharp increase in various forms of viral illnesses, including dengue, H1N1, hepatitis A and the newer coronavirus.

For more market insight, request a sample of this report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12943

Vials and pre-filled syringes are two of the most common forms of vaccine packaging generally preferred in clinical research and diagnostic centers. The practical use and affordability of packaging along with the availability of glass and plastic materials is driving the global vaccine packaging market. Vials were identified as the most widely used type of packaging, followed by pre-filled syringes. The vials segment is expected to hold around 4 / 5th of the market share by the end of 2021.

Highlights of the vaccine packaging market

The global vaccine packaging market is expected to record remarkable growth amid COVID-19. IMF forecast it would post a CAGR of 13.1% between 2020 and 2030

The United States is expected to become dominant in North America, reaching a valuation of nearly $ 248 million by 2021

The UK will remain one of the key vaccine packaging markets in Europe, with a valuation exceeding US $ 62 million by 2021

Germany and France will continue to show strong demand for vaccine packaging

While Japan and South Korea are expected to show strong demand, China is expected to remain dominant in the vaccine packaging market in East Asia

“Some of the major players in the market are aiming to expand their production facilities in order to meet the global demand for vials and pre-filled syringes for COVID-19 vaccines,” an IMF analyst said.

For any queries related to the report, ask an analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-12943

Durability associated with packaging vaccines for growth

The sustainability of packaging is a growing area of ​​dialogue and coordination between states, industry, academia and regulators. To improve the natural, social and economic resilience of packaging, product advancements and content production would be crucial. Glass vials significantly dominate the overall vaccine packaging market as they do not react with the contents and can deliver multiple doses in one package. In addition, as plastic ampoules to reduce the risk of contamination, the consumption of these products is expected to increase by multiples in the coming years. However, in terms of durability benefits, pre-filled syringes are now taking over from vials.

Being unit dose and ready for administration, pre-filled syringes are “safe by design” due to their inherent ease of use, elimination of many error-prone steps in vaccine preparation and administration, a reduction in the risk of syringe contamination, and a guarantee of the correct dose for each injection. In comparison, tear-off labels printed on pre-filled vaccine syringes make it easier to record lot numbers and update the patient’s immunization record faster than vials.

Impact of COVID-19 on the vaccine packaging market

After COVID-19, the global vaccine packaging market is expected to register impressive growth. This is due to the increasing consumption of vaccines among consumers to reduce the impact of viral infection and maintain good health, amid COVID-19. The vaccine packaging market is expected to grow at a double-digit growth rate as the demand for vaccines grows exponentially in diagnostic centers, hospitals and other healthcare organizations. According to the IMF analysis, the global adoption of vaccine packaging will increase by almost 3.5 times the value over 2020-2030.

QR codes and RFID tags are already used by manufacturers of vaccine packaging to ensure vaccine safety during packaging, transport and storage. Therefore, most of the key players adopt a fully automated assembly line and minimize the direct contact of human beings in the product flow.

For example, the solution adopted by Pfizer, Inc. to package vaccine doses for delivery to the USA is “Ecoplat Plus” from ROBOPAC USA. It uses stretch film, a wrapping turntable incorporating state-of-the-art technology that ensures peak efficiency through its durability, power and ease of use, including optimal product safety.

We offer tailor-made solutions to meet your needs, request customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-12943

Vaccine Packaging Market Landscape

Gerresheimer AG, West Pharmaceutical Services, Inc., Becton, Dickinson & Company, SCHOTT AG, SGD SA, Catalent, Inc, Stevanato Group, Nipro Corporation, Piramal Glass Private Limited and UDG Healthcare plc. are considered to be the major players in the vaccine packaging market. Level 3 market players hold 70-80% of the global vaccine packaging market. In conclusion, the main players contribute almost 20 to 30% of global demand.

Vaccine Packaging Market Report

Future Market Insights in its new report offers an unbiased analysis of the global vaccine packaging market, analyzing the historical demand for 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections in the vaccine packaging market on the basis of the type of packaging (vials, pre-filled syringes, ampoules & sachets & sachets), material (plastic, glass, polystyrene and others (films). metals)) and end-use (diagnostic centers, clinical research organization and other healthcare units) in seven regions.

Buy [email protected] https://www.futuremarketinsights.com/checkout/12943

Ankush Nikam
IMF
+91 9096684197
write us here


Share.

Comments are closed.